Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001415889-15-001475
Filing Date
2015-04-30
Accepted
2015-04-30 06:45:12
Documents
5
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A mbvx10ka_dec312014.htm 10-K/A 600670
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER REQUIRED BY SECTION 302 OF THE SARB ex31-1.htm EX-31.1 22101
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER REQUIRED BY SECTION 302 OF THE SARB ex31-2.htm EX-31.2 19696
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ex32-1.htm EX-32.1 8636
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ex32-2.htm EX-32.2 9151
  Complete submission text file 0001415889-15-001475.txt   661385
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

EIN.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-31265 | Film No.: 15815054
SIC: 2834 Pharmaceutical Preparations